Timothy Cowper

Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom.

Clipper Ventures Plc operates as a sailing school. It develops and promotes international marine events. The company was founded by William C. Ward and Robin Knox-Johnston on August 4, 1995 and is headquartered in Gosport, the United Kingdom.

Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA.

Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom.